stocks ARIAD Pharmaceuticals Inc

What to watch during health-care investing's biggest week of the year
11:30 AM ET Mon, 8 Jan 2018
Investors at the conference want to know if companies are planning more M&A in the wake of tax reform. Pricing practices could be in focus.
Japanese shares fall as yen strength weighs
2:23 AM ET Tue, 10 Jan 2017
Asian markets were under pressure on Tuesday, as investor sentiment soured after the Dow retreated further from the 20,000 mark.
US dealmaking kicks off 2017 with biggest start in 7 years
7:52 PM ET Mon, 9 Jan 2017
More than $18 billion in U.S. deals were announced Monday, bringing 2017's deal values to more than twice the same period last year.
Nasdaq closes at record high despite energy weakness; Apple, biotechs rise 1%
11:23 AM ET Tue, 10 Jan 2017
U.S. stocks traded closed mixed on Monday, pulling back from record levels, as investors geared up for the start of earnings season.
Ariad Pharmaceuticals shares skyrocket more than 70 percent after it strikes deal with Takeda
4:28 PM ET Mon, 9 Jan 2017
Ariad Pharmaceuticals investors are having a good day.
Japan's Takeda to buy US cancer drug maker Ariad in $5.2 billion deal
11:10 AM ET Mon, 9 Jan 2017
Japan's Takeda Pharmaceutical said on Monday it would acquire cancer drugmaker Ariad Pharmaceuticals Inc in a deal valued at $5.20 billion.
Ariad to be acquired by Takeda for $5.2B
9:23 AM ET Mon, 9 Jan 2017
CNBC's Meg Tirrell reports Takeda is buying cancer drugmaker Ariad in a $5.2 billion deal.
Cramer explains why drug stocks are being sacrificed to the cyclical plays
1:34 PM ET Mon, 14 Nov 2016
Jim Cramer goes through a lightning round of callers and quickly gives his take on various caller stocks.
Pharma surges on Trump win
3:36 PM ET Wed, 9 Nov 2016
CNBC’s Meg Tirrell discusses the surge in biotech and pharmaceuticals following Trump’s victory, as well as what investors expect from here.
Eli Lilly shares fall on Bernie Sanders tweet
4:40 PM ET Tue, 1 Nov 2016
US Senator Bernie Sanders tweeted about the price of Eli Lilly's Humalog insulin, sending the company's stock down more than 1 percent.
Drug price pressure
1:54 PM ET Tue, 25 Oct 2016
CNBC's Meg Tirrell reports the latest news in pharma, including Novartis under pressure, and Merck's FDA drug approval.
Thanks to the Nordic American disaster, Cramer's not recommending this group anymore
7:32 PM ET Thu, 20 Oct 2016
Jim Cramer quickly provided his opinion on various stocks, including this one that left a sour taste from cutting the dividend.
Washington's next biotech target?
5:53 PM ET Thu, 20 Oct 2016
CNBC's Meg Tirrell reports the latest surrounding Ariad Pharmaceuticals and the company's drug price hike.
Ariad shares sink after Bernie Sanders demands info on its leukemia drug
4:42 PM ET Thu, 20 Oct 2016
Sen. Bernie Sanders and Rep. Elijah Cummings request details after Ariad repeatedly raised the price of its drug.
Ariad cancer drug pricing under congressional scrutiny
1:27 PM ET Thu, 20 Oct 2016
CNBC's Meg Tirrell reports the latest on a tweet sent by Sen. Bernie Sanders about Ariad Pharmaceuticals' cancer drug pricing.
California's drug pricing bill
2:26 PM ET Mon, 17 Oct 2016
CNBC's Meg Tirrell reports the latest on the controversy surrounding the California Drug Price Relief Act including the Bernie Sanders' support for the proposition.
Bernie Sanders tweet sends shares of Ariad Pharmaceuticals down 15%
12:21 AM ET Sat, 15 Oct 2016
Ariad Pharmaceuticals plunged as much as 15 percent after Sen. Bernie Sanders criticized the price of the company's leukemia drug.
Martin Shkreli trial set for June
5:48 PM ET Fri, 14 Oct 2016
CNBC's Meg Tirrell reports the latest details surrounding Martin Shkreli and his appearance back in court today facing fraud charges.
Cramer: The right way to play master limited partnerships
7:32 PM ET Thu, 13 Oct 2016
Jim Cramer rattles off his take on caller favorite stocks, including master limited partnerships like Kinder Morgan.
Analyst: Three things are pushing Mylan higher
2:31 PM ET Mon, 10 Oct 2016
Michael Yee, RBC Capital Markets biotech analyst, shares his take on big biotech movers including Mylan, Tesaro and more.

« First

Next » | Last »

var mps=mps||{}; mps._queue=mps._queue||{}; mps._queue.gptloaded=mps._queue.gptloaded||[]; mps._queue.gptloaded.push(function() { (mps && mps.insertAd && mps.insertAd('#dart_wrapper_badgec', 'badgec')); }); stocks ARIAD Pharmaceuticals Inc

stocks ARIAD Pharmaceuticals Inc